Results 281 to 290 of about 198,724 (360)

An umbrella meta-analysis of microbial therapy on hepatic steatosis, fibrosis, and liver stiffness in metabolic dysfunction-associated steatotic liver disease. [PDF]

Front Nutr
Kurban G, Chen X, Jin X, Xia H, Wang S, Sun G.   +5 more
europepmc   +1 more source

The Proteomic Profiling of Circulating Extracellular Vesicles of Western Diet and Chemical‐Induced Murine MASH Model

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Metabolic dysfunction‐associated steatotic liver disease (MASLD) is an increasingly prevalent chronic liver condition that can progress to severe complications such as metabolic dysfunction‐associated steatohepatitis (MASH). Despite its growing burden, there are no reliable non‐invasive biomarkers for tracking disease progression.
Szu‐Jen Wang, Yung‐Ho Wang, Jee‐Fu Huang, En‐Sheng Lin, Wei‐Shiun Chen, Chia‐Yang Li, Chia‐Yen Dai, Wan‐Long Chuang, Ming‐Lung Yu, Shu‐Chi Wang   +9 more
wiley   +1 more source

Assessment of the Diagnostic Performance and Clinical Impact of AI in Hepatic Steatosis: Systematic Review and Meta-Analysis.

J Med Internet Res
Song J, Liu D, Li J, Cong H, Deng R, Lu Y, Sun J, Zhang J.   +7 more
europepmc   +1 more source

Cholesterol-containing lipid crystals can directly stiffen the rat steatotic liver before fibrosis. [PDF]

Proc Natl Acad Sci U S A
Li D, Loneker AE, Safraou Y, Ford J, Mihelc E, Sakane S, Kisseleva T, Levental KR, Levental I, Sack I, Janmey PA, Wells RG.   +11 more
europepmc   +1 more source

Metabolic Dysfunction‐Associated Steatotic Liver Disease After Hepatitis C Virus Cure

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Hepatitis C virus (HCV) infection is an infectious disease carrying a high risk of metabolic disorders. Chronic HCV (CHC) patients can possess extrahepatic manifestations such as diabetes, steatotic liver disease (SLD), and other metabolic alterations.
Chung‐Feng Huang, Jee‐Fu Huang, Ming‐Lung Yu, Wan‐Long Chuang   +3 more
wiley   +1 more source

Metabolic Dysfunction-associated Steatotic Liver Disease Alters Fatty Acid Profiles in the Liver and Adipose Tissue.

J Clin Endocrinol Metab
Palomurto S, Virtanen KA, Kärjä V, Schwab U, Kaminska D, Käkelä P, Pihlajamäki J, Männistö V.   +7 more
europepmc   +1 more source

Predictive Value of Hepatic Steatosis for Postoperative Recurrence in Hepatitis B-Related Hepatocellular Carcinoma: Development of a Machine Learning-Based Prognostic Model. [PDF]

J Hepatocell Carcinoma
Hao A, Li C, Sun R, Tan B, Shao G, Li K, Li N, Hu W, Qu C, Cao J.   +9 more
europepmc   +1 more source

Metabolic dysfunction-associated steatotic liver disease in Egypt: Epidemiology, risk factors and management challenges. [PDF]

World J Gastroenterol
Abdelhamed W, Amin M, Waked I, El-Kassas M.   +3 more
europepmc   +1 more source

Towards Comprehensive Chronic Disease Control: Prevention, Early Detection, and Integrated Management

Medicine Bulletin, EarlyView.
ABSTRACT Chronic non‐communicable diseases (NCDs), including cardiovascular disease, diabetes, cancer, and chronic respiratory conditions, represent the leading causes of morbidity and mortality worldwide. This review examines comprehensive strategies across the continuum of care (from primary prevention and early screening to timely diagnosis ...
Ping Sun, Zhengwei Wan, Yuping Liu
wiley   +1 more source